MedTrace Logo

Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease

NCT04998214 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-02-06

No results posted yet for this study

Summary

To measure the frequency of persistent liver dysfunction (raised liver enzymes, serum albumin, prothrombin time, etc) in recovered COVID -19 patients.

To compare the hepatic manifestations in post COVID -19 patients with and without liver disease

Conditions

Interventions

DIAGNOSTIC_TEST

liver function , prothrombin time , INR , US .

analytic

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Khaled Abu Bakr · Assiut University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-19
Primary Completion
2023-04-01
Completion
2023-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04998214 on ClinicalTrials.gov